Cherry JD. Parvovirus infections in children and adults. Adv Pediatr. 1999;46:245-269.
Elzagallaai AA, Knowles SR, Rieder MJ, et al. Patch testing for the diagnosis of anticonvulsant hypersensitivity syndrome: a systematic review. Drug Saf. 2009;32:391-408.
1. Arndt KA, Jick H. Rates of cutaneous reactions to drugs. A report from the Boston Collaborative Drug Surveillance Program. JAMA. 1976;235:918-923.
2. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med. 1994;331:1272-1285.
3. Bigby M. Rates of cutaneous reactions to drugs. Arch Dermatol. 2001;137:765-770.
4. Revuz J, Valeyrie-Allanore J. Drug Reactions. In: Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology. Elsevier; 2003:333-354.
5. Bousquet PJ, Kvedariene V, Co-Minh HB, et al. Clinical presentation and time course in hypersensitivity reactions to beta-lactams. Allergy. 2007;62:872-876.
6. Cacoub P, Musette P, Descamps V, et al. The DRESS syndrome: a literature review. Am J Med. 2011;124:588-597.
7. Tas S, Simonart T. Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update. Dermatology. 2003;206:353-356.
8. Mancini AJ, Shani-Adir A. Other viral diseases. In: Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology. Elsevier; 2003:1255-1320.
9. Renn CN, Straff W, Dorfmuller A, et al. Amoxicillin-induced exanthema in young adults with infectious mononucleosis: demonstration of drug-specific lymphocyte reactivity. Br J Dermatol. 2002;147:1166-1170.
10. Cherry JD. Parvovirus infections in children and adults. Adv Pediatr. 1999;46:245-269.
11. Porras B, Costner M, Friedman-Kien AE, et al. Update on cutaneous manifestations of HIV infection. Med Clin North Am. 1998;82:1033-1080.
12. Cherry JD. Viral exanthems. Curr Probl Pediatr. 1983;13:1-44.
13. Blume JE, Levine EG, Heymann WR. Bacterial diseases. In: Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology. Elsevier; 2003:1117-1144.
14. Berbis, P. Rickettsial diseases. In: Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology. Elsevier; 2003:1165-1170.
15. Barron KS. Kawasaki disease in children. Curr Opin Rheumatol. 1998;10:29-37.
16. Hazin R, Ibrahimi OA, Hazin MI, et al. Stevens-Johnson syndrome: pathogenesis, diagnosis, and management. Ann Med. 2008;40:129-138.
17. New Zealand Dermatological Society Incorporated. Stevens Johnson syndrome / toxic epidermal necrolysis. January 2016. http://dermnetnz.org (last accessed 17 October 2016).
18. Tan EH, Chan A. Evidence-based treatment options for the management of skin toxicities associated with epidermal growth factor receptor inhibitors. Ann Pharmacother. 2009;43:1658-1666.
19. Hunziker T, Kunzi UP, Braunschweig S, et al. Comprehensive hospital drug monitoring (CHDM): adverse skin reactions, a 20-year survey. Allergy. 1997;52:388-393.
20. Celebi G, Pişkin N, Aydemir H, et al. Evaluation of 35 adult measles cases detected in a measles outbreak [in Turkish]. Mikrobiyol Bul. 2007;41:79-86.
21. Kimberlin DW. Human herpesviruses 6 and 7: identification of newly recognized viral pathogens and their association with human disease. Pediatr Infect Dis J. 1998;17:59-67.
22. Buckingham SC, Marshall GS, Schutze GE, et al. Clinical and laboratory features, hospital course, and outcome of Rocky Mountain spotted fever in children. J Pediatr. 2007;150:180-184.
23. Mehrpoor G, Owlia MB, Soleimani H, et al. Adult-onset Still's disease: a report of 28 cases and review of the literature. Mod Rheumatol. 2008;18:480-485.
24. Falcini F, Cimaz R. Juvenile rheumatoid arthritis. Curr Opin Rheumatol. 2000;12:415-419.
25. Stary A. Sexually transmitted diseases. In: Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology. Elsevier; 2003:1271-1281.
26. Gemmell CG. Staphylococcal scalded skin syndrome. J Med Microbiol. 1995;43:318-327.
27. Cribier B, Piemont Y, Grosshans E. Staphylococcal scalded skin syndrome in adults. A clinical review illustrated with a new case. J Am Acad Dermatol. 1994;30:319-324.
28. Hajjeh RA, Reingold A, Weil A, et al. Toxic shock syndrome in the United States: surveillance update, 1979-1996. Emerg Infect Dis. 1999;5:807-810.
29. Reingold AL, Hargrett NT, Shands KN, et al. Toxic shock syndrome surveillance in the United States, 1980 to 1981. Ann Intern Med. 1982;96:875-880.
30. Evans AS, Niederman JC, Cenabre LC, et al. A prospective evaluation of heterophile and Epstein-Barr virus-specific IgM antibody tests in clinical and subclinical infectious mononucleosis: Specificity and sensitivity of the tests and persistence of antibody. J Infect Dis. 1975;132:546-554.
31. Ferry T, Thomas D, Bouchut JC, et al. Early diagnosis of staphylococcal toxic shock syndrome by detection of the TSST-1 Vbeta signature in peripheral blood of a 12-year-old boy. Pediatr Infect Dis J. 2008;27:274-277.
32. Nigen S, Knowles SR, Shear NH. Drug eruptions: approaching the diagnosis of drug-induced skin diseases. J Drugs Dermatol. 2003;2:278-299.
33. Aberer W, Bircher A, Romano A, et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general consideration. Allergy. 2003; 58:854-863.
34. Lammintausta K, Kortekangas-Savolainen O. The usefulness of skin tests to prove drug hypersensitivity. Br J Dermatol. 2005;152:968-974.
35. Elzagallaai AA, Knowles SR, Rieder MJ, et al. Patch testing for the diagnosis of anticonvulsant hypersensitivity syndrome: a systematic review. Drug Saf. 2009;32:391-408.
36. Cham PM, Warshaw EM. Patch testing for evaluating drug reactions due to systemic antibiotics. Dermatitis. 2007;18:63-77.
37. Lammintausta K, Kortekangas-Savolainen O. Oral challenge in patients with suspected cutaneous adverse drug reactions: findings in 784 patients during a 25-year-period. Acta Derm Venereol. 2005;85:491-496.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台